Clinical Study Results
How many participants had serious adverse reactions?
None of the participants had a serious adverse reaction during this study.
How many participants had adverse reactions?
• 1.6% of participants had an adverse reaction during the study. This was
1 out of 62 participants.
• 3.4% of participants who took SZC had an adverse reaction during the study.
This was 1 out of 29 participants.
• None of the participants who took the placebo had an adverse reaction during
the study.
None of the participants stopped taking study treatment because of adverse
reactions they had during the study.
What adverse reactions did the participants have?
The only adverse reaction was high blood glucose. This happened in 3.4% of the
participants who took SZC. This was 1 out of 29 participants who took SZC.
How has this study helped patients and
researchers?
This study helped researchers learn how SZC might be used in the future to treat
participants who need emergency treatment for high blood potassium.
Researchers look at the results of many studies to decide which treatments work
best and are safest. This summary shows only the main results from this one study.
Other studies may provide new information or different results.
Further clinical studies with SZC are planned.
7